ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.91
0.06%
US Tech 100
18,206.20
0.05%
S&P 500
5,315.21
0.13%
US Dollar vs CAD
1.36495
0.19%
Bitcoin
69,637.16
-2.54%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aptorum Group Ltd (APM)

  7. Aptorum Group Ltd (APM) News

APM

Aptorum (APM)

Aptorum Group Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:APM
DateTimeSourceHeadlineSymbolCompany
04/30/20248:15AMBusiness WireAptorum Group Limited Reports 2023 Fiscal Year End Financial Results and Provides Business UpdateNASDAQ:APMAptorum Group Ltd
03/06/20247:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
03/06/20247:00AMBusiness WireAptorum Group Ltd Announces Entering into an Agreement and Plan of Merger with YOOV Group Holding Ltd and a Split-off Agreement to Separate its Legacy BusinessNASDAQ:APMAptorum Group Ltd
12/22/20233:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
12/22/20233:30PMBusiness WireAptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2023NASDAQ:APMAptorum Group Ltd
12/21/20233:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
12/21/20233:30PMBusiness WireAptorum Group Limited Announces Results of 2023 Annual General Meeting of ShareholdersNASDAQ:APMAptorum Group Ltd
11/30/20233:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
11/21/20239:25AMEdgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:APMAptorum Group Ltd
11/16/202310:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
11/16/202310:00AMBusiness WireAptorum Group Limited to Hold Annual General Meeting of Shareholders on December 20, 2023NASDAQ:APMAptorum Group Ltd
09/11/20233:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
08/10/20235:07AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
08/10/20231:57AMBusiness WireAptorum Group Receives Nasdaq Approval to Transfer Listing to Nasdaq Capital MarketsNASDAQ:APMAptorum Group Ltd
07/14/20233:30PMEdgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:APMAptorum Group Ltd
06/30/20233:31PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
06/30/20233:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:APMAptorum Group Ltd
06/22/20237:00AMBusiness WireAptorum Group Updates on a Phase 1b/2a Clinical Trial for Repurposed Small Molecule Drug SACT-1 for NeuroblastomaNASDAQ:APMAptorum Group Ltd
06/09/20233:31PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APMAptorum Group Ltd
06/09/20233:30PMBusiness WireAptorum Group Limited Announces Voluntary Delisting from Euronext ParisNASDAQ:APMAptorum Group Ltd
05/24/20238:01AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APMAptorum Group Ltd
05/22/20235:02AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:APMAptorum Group Ltd
05/17/20233:31PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:APMAptorum Group Ltd
05/08/20238:00AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APMAptorum Group Ltd
05/05/20233:31PMBusiness WireAptorum Group Receives Nasdaq Notification of Minimum Stockholders’ Equity DeficiencyNASDAQ:APMAptorum Group Ltd
05/03/20238:29AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:APMAptorum Group Ltd
05/01/20237:00AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APMAptorum Group Ltd
05/01/20237:00AMBusiness WireAptorum Therapeutics Limited Enters Into Letter of Intent and Term Sheet with Universal Sequencing Technology Corporation to Merge with Aptorum Group’s Subsidiary Paths Innovations LimitedNASDAQ:APMAptorum Group Ltd
04/28/20238:44AMBusiness WireAptorum Group Limited Reports 2022 Fiscal Year End Financial Results and Provides Business UpdateNASDAQ:APMAptorum Group Ltd
04/28/20238:19AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:APMAptorum Group Ltd
 Showing the most relevant articles for your search:NASDAQ:APM

Your Recent History

NASDAQ
GFN
General Finance
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved